AAAAAA
Results:
1-11
|
Results: 11
Authors:
HALLER DG
SAROSY G
THURN A
HUBBARD SM
Citation: Dg. Haller et al., PDQ - A COMPREHENSIVE CANCER INFORMATION DATABASE - THE US EXPERIENCE, European journal of cancer, 33, 1997, pp. 1324-1324
Authors:
FIGG WD
CHRISTIAN MC
LUSH R
LINK CJ
DAVIS P
KOHN E
SAROSY G
ROTHENBERG ML
WEISS RB
RYAN N
JACOBS J
REED E
Citation: Wd. Figg et al., PHARMACOKINETICS OF ELEMENTAL PLATINUM (ULTRAFILTRATE AND TOTAL) AFTER A 30 MINUTE INTRAVENOUS-INFUSION OF ORMAPLATIN, Biopharmaceutics & drug disposition, 18(4), 1997, pp. 347-359
Authors:
REED E
SAROSY G
KOHN E
CHRISTIAN M
LINK CJ
GOLDSPIEL B
DAVIS P
JACOB J
MAHER M
Citation: E. Reed et al., A PHASE-I STUDY OF PACLITAXEL AND CYCLOPHOSPHAMIDE IN RECURRENT ADENOCARCINOMA OF THE OVARY, Gynecologic oncology, 61(3), 1996, pp. 349-353
Authors:
KOHN EC
REED E
SAROSY G
CHRISTIAN M
LINK CJ
COLE K
FIGG WD
DAVIS PA
JACOB J
GOLDSPIEL B
LIOTTA LA
Citation: Ec. Kohn et al., CLINICAL INVESTIGATION OF A CYTOSTATIC CALCIUM INFLUX INHIBITOR IN PATIENTS WITH REFRACTORY CANCERS, Cancer research, 56(3), 1996, pp. 569-573
Authors:
LINK CJ
REED E
SAROSY G
KOHN EC
Citation: Cj. Link et al., BORDERLINE OVARIAN-TUMORS, The American journal of medicine, 101(2), 1996, pp. 217-225
Authors:
FIGG WD
COLE KA
REED E
STEINBERG SM
PISCITELLI SC
DAVIS PA
SOLTIS MJ
JACOB J
BOUDOULAS S
GOLDSPIEL B
SAROSY G
LIOTTA LA
KOHN EC
Citation: Wd. Figg et al., PHARMACOKINETICS OF ORALLY-ADMINISTERED CARBOXYAMIDO-TRIAZOLE, AN INHIBITOR OF CALCIUM-MEDIATED SIGNAL-TRANSDUCTION, Clinical cancer research, 1(8), 1995, pp. 797-803
Authors:
REED E
KOHN EC
SAROSY G
DABHOLKAR M
DAVIS P
JACOB J
MAHER M
Citation: E. Reed et al., PACLITAXEL, CISPLATIN, AND CYCLOPHOSPHAMIDE IN HUMAN OVARIAN-CANCER -MOLECULAR RATIONALE AND EARLY CLINICAL-RESULTS, Seminars in oncology, 22(3), 1995, pp. 90-96
DOSE-INTENSE TAXOL - HIGH RESPONSE RATE IN PATIENTS WITH PLATINUM-RESISTANT RECURRENT OVARIAN-CANCER
Authors:
KOHN EC
SAROSY G
BICHER A
LINK C
CHRISTIAN M
STEINBERG SM
ROTHENBERG M
ADAMO DO
DAVIS P
OGNIBENE FP
CUNNION RE
REED E
Citation: Ec. Kohn et al., DOSE-INTENSE TAXOL - HIGH RESPONSE RATE IN PATIENTS WITH PLATINUM-RESISTANT RECURRENT OVARIAN-CANCER, Journal of the National Cancer Institute, 86(1), 1994, pp. 18-24
Authors:
BICHER A
KOHN E
SAROSY G
DAVIS P
ADAMO DO
JACOB J
CHRISTIAN M
REED E
Citation: A. Bicher et al., THE ABSENCE OF CUMULATIVE BONE-MARROW TOXICITY IN PATIENTS WITH RECURRENT ADENOCARCINOMA OF THE OVARY RECEIVING DOSE-INTENSE TAXOL AND GRANULOCYTE-COLONY STIMULATING FACTOR, Anti-cancer drugs, 4(2), 1993, pp. 141-148
Authors:
JAMISDOW CA
KLECKER RW
SAROSY G
REED E
COLLINS JM
Citation: Ca. Jamisdow et al., STEADY-STATE PLASMA-CONCENTRATIONS AND EFFECTS OF TAXOL FOR A 250-MG M(2) DOSE IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR INPATIENTS WITH OVARIAN-CANCER/, Cancer chemotherapy and pharmacology, 33(1), 1993, pp. 48-52
Authors:
SAROSY G
REED E
Citation: G. Sarosy et E. Reed, TAXOL DOSE INTENSIFICATION AND ITS CLINICAL IMPLICATIONS, Journal of the National Medical Association, 85(6), 1993, pp. 427-431
Risultati:
1-11
|